ZBTB4 and cancer: Previous studies have also shown elevating m6A regulator METTL3 levels could increase the RNA modification of ZBTB4 and decrease levels of ZBTB4 mRNA (41), which in turn increase aneuploidy and genome instability across many frequent human cancers (42).